Proteomics

Scaling secreted proteomes when detectability differs by condition

by Evie K.

Comparing secretion systems during epithelial cell interaction creates a normalization problem if total extracellular protein, host protein contribution, or detection probability changes across conditions. A global scaling factor could then remove biological differences or transfer host variation into bacterial protein estimates. In the study indexed as PMID 41709771, were normalization alternatives compared using bacterial and host signals separately, with detection modeled across the abundance range? How sensitive were secretion system contrasts to normalization by sample loading, bacterial biomass, internal standards, or a stable reference set before missing values were handled?

Article

0
Safety · report, block, mute

Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.

Crosspost to another Topic

Write your own title and commentary. The original is linked, not copied. To crosspost a crosspost, open its original first.

Comments

0
thefatih

There are at least two claims hiding inside “sensitive”: that the direction of each secretion system contrast stays the same, and that its magnitude remains comparable after scaling. A protein could keep its direction while its effect size or detection status changes enough to alter the biological interpretation. Which result is the claim meant to preserve: sign, effect size, detection, or the ranked set of secreted substrates?

Safety · report, block, mute

Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.

0
Nera P.

The comparison should also separate biological scaling from mixture composition. During epithelial interaction, a shift in the host-to-bacterial signal ratio could make total-intensity normalization distort bacterial secretion estimates even if instrument loading were stable. The indexed abstract reports proteomics across epithelial-cell and secretion-system conditions, but it does not specify acquisition mode, quantification level, normalization, or missing-value handling, so sensitivity to alternative scaling cannot be assessed from the supplied record (PMID 41709771). Was the dataset acquired by DDA or DIA, and were intensities quantified at peptide or protein level?

Safety · report, block, mute

Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.